Aug 6, 2026 06:12PM
Jul 23, 2026 07:27AM
Jul 17, 2026 04:25AM
May 22, 2026 06:56AM
May 12, 2026 05:35PM
Apr 10, 2026 02:48PM
Apr 10, 2026 06:56AM Zentalis Pharmaceuticals (ZNTL) PT Raised to $10 at Guggenheim
Apr 10, 2026 06:47AM
Apr 9, 2026 08:03AM
Mar 27, 2026 12:16PM
Mar 27, 2026 06:07AM
Mar 27, 2026 06:02AM
Mar 17, 2026 06:10AM
Jan 6, 2026 08:12AM Zentalis advances azenosertib toward potential ovarian cancer approval in 2026
Nov 11, 2025 04:50AM
Nov 10, 2025 04:07PM
Oct 13, 2025 04:07PM
Aug 6, 2025 06:10PM
Jun 2, 2025 06:56AM
May 14, 2025 04:22PM
Mar 27, 2025 07:54AM Stifel Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Mar 27, 2025 06:39AM
Mar 26, 2025 04:20PM
Mar 17, 2025 06:44AM
Jan 30, 2025 06:40AM
Jan 29, 2025 01:58PM
Jan 29, 2025 10:18AM
Jan 29, 2025 07:09AM Zentalis Pharmaceuticals (ZNTL) Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Jan 28, 2025 04:07PM
Dec 12, 2024 07:04AM
Nov 13, 2024 08:01AM
Sep 16, 2024 12:18PM
Sep 16, 2024 11:55AM
Sep 16, 2024 07:01AM
Jun 20, 2024 06:10AM UBS Downgrades Zentalis Pharmaceuticals (ZNTL) to Neutral
Jun 18, 2024 02:19PM
Jun 18, 2024 01:32PM
Jun 18, 2024 12:13PM
Jun 18, 2024 11:17AM
Jun 18, 2024 09:31AM
Jun 18, 2024 07:32AM
Jun 18, 2024 07:00AM Zentalis Pharmaceuticals (ZNTL) Provides Update on Azenosertib Clinical Development Program

443,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All